Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Recruiting
N/A
Interventional Study
Melanoma Stage III
B-cell Non Hodgkin Lymphoma
Pediatric ALL
Childhood Non-Hodgkin Lymphoma
Acute Lymphatic Leukemia
Chronic Lymphatic Leukemia
Melanoma Stage IV
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 40 (estimated)
- Sponsor
- Miltenyi Biomedicine GmbH · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this Long-Term Follow-Up Trial is to assess long-term safety and efficacy of Miltenyi CAR T treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient underwent treatment with a Miltenyi CAR T cell therapy in one of the parent trials at least 12 months prior to enrollment in long-term follow-up.
* Patient has provided informed consent prior to enrollment.
Exclusion Criteria:
* No exclusion criteria
Contacts